ValtedSeq

Biotechnology Research • Gaithersburg, Maryland, United States • 1-10 Employees

Company overview

Headquarters	704 Quince Orchard Rd, Suite 320, Gaithersburg, Maryland 20878, US
Phone number	+16507395175
Website	valtedseq.com
NAICS	541714
Employees	1-10
Socials

Key Contact at ValtedSeq

Bardia Nezami

Chief Executive Officer

ValtedSeq Email Formats

ValtedSeq uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@valtedseq.com), used 83.3% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@valtedseq.com	83.3%
{first initial}{last name}	jdoe@valtedseq.com	16.7%

About ValtedSeq

Valted Seq is a discovery stage biopharmaceutical company spearheaded by world-renowned scientists Dr. Ted Dawson and Dr. Valina Dawson of Johns Hopkins University. The company was founded on the belief that a deeper understanding of neurodegenerative pathways is essential to develop precision therapeutics and identify novel biomarkers for some of the most challenging neurodegenerative diseases, including Alzheimer’s and Parkinson’s. Valted Seq is part of the D&D Pharmatech/Neuraly family of companies, which works hand in hand with leading medical research institutions to advance groundbreaking healthcare innovations. ValtedSeq is focused on the advancement of NextGen sequencing at the single cell level, as well as developing assays for diagnostic biomarkers,

ValtedSeq revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	$10,000,000